Objective(s)-To characterize the longitudinal patterns of antipsychotic treatment and to investigate the relationship between antipsychotic treatment patterns and acute hospitalizations among adults with schizophrenia. We hypothesized that continuous antipsychotic treatment would be associated with fewer hospitalizations and shorter lengths of stay.Method-Seven years of retrospective Maryland Medicaid administrative data were used to examine inpatient medical encounters and outpatient psychotropic treatment in community-based settings from 1993 through 2000. The sample consisted of 1,727 adults continuously enrolled in the Maryland Medicaid program from July 1992 through June 1994, and diagnosed with schizophrenia. The main outcome measures were a) any schizophrenia hospitalization; b) number of schizophrenia hospitalizations; and c) inpatient days associated with a primary diagnosis of schizophrenia.Results-The average duration of antipsychotic use was six months in any single year and four and one-half years across the entire study period. Compared to individuals with a more continuous pattern of antipsychotic treatment, individuals with moderate or light use had odds of hospitalization for schizophrenia that were 52 or 72 percent greater (95%CI: 30−75% greater, 49−100% greater respectively). Light users of antipsychotics have an average length of stay per hospitalization that is approximately 20 percent longer than the average for continuous users (95%CI: 2−39% longer). Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. (Lehman et al. 2004;Lehman et al. 1998). This results in fewer symptoms, a less episodic course (APA 1997), better clinical and functional outcomes for adults with schizophrenia (Lehman et al. 1995;Verdoux et al. 2000), and fewer relapses (Herz et al. 1991;Schooler 2006).
Conclusions-Findings
NIH Public AccessDespite this evidence, research on outpatient utilization spanning 1987−1997 shows that it rarely is continuous in a given year (dosReis et al. 2002;McCombs et al. 1999;Menzin et al. 2003;Mojtabai et al. 2002;Vanelli et al. 2001;Velligan et al. 2003;Williams et al. 1999).Only 12−30% of individuals received continuous antipsychotic treatment over a one year period (McCombs et al. 1999;Williams et al. 1999). From 17−24% of adults with schizophrenia do not receive medication in outpatient settings (dosReis et al. 2002;McCombs et al. 1999). Prescription refills over a nine-month period in 1998−1999 indicate that approximately 30% of individuals discontinue antipsychotic medication within three months after initiating treatment (Vanelli et al. 200...